Mayo Clinic-backed Pendulum near doubled its total funding in a round that will support increased manufacturing of its lead probiotic product.

Pendulum Therapeutics, a US-based microbiome-focused medical product developer backed by medical research and care provider Mayo Clinic, has received $54m in a series C round led by Meritech Capital. Meritech was joined by existing investors including fellow venture capital firms Sequoia Capital, True Ventures and Khosla Ventures. Craig Sherman, a general partner at Meritech, is…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.